The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 435.00
Ask: 445.00
Change: 15.00 (3.53%)
Spread: 10.00 (2.299%)
Open: 425.00
High: 445.00
Low: 425.00
Prev. Close: 425.00
MPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Lambert and Trading Update

1 May 2019 07:00

RNS Number : 6484X
Mpac Group PLC
01 May 2019
 

1 May 2019

 

Mpac Group plc

("Mpac" or the "Company")

Acquisition of Lambert Automation Limited and Trading Update

 

Mpac Group plc (AIM: MPAC), the global packaging solutions group, is pleased to announce that it has acquired the entire issued share capital of Lambert Automation Limited ("Lambert") for an initial consideration of £15.0 million to be paid in cash (the "Acquisition"). Further deferred and earn-out consideration may become payable as set out below.

Lambert was founded in 1973 and is a provider of technology leading automation solutions to the medical and consumer healthcare markets. Lambert is based in Tadcaster, UK and employs approximately 160 staff. The audited financial statements of Lambert for the year to 31 December 2018 showed revenue of £17.9m and profit before tax of £1.3m including depreciation and amortisation of £0.8m and an interest credit of £1.1m, including waived preference share interest. Audited net assets at the same date were £7.1m, including net cash of £2.3m and goodwill of £4.9m.

Sales and earnings before interest, tax, depreciation and amortisation ("EBITDA") for the previous three financial years were as follows:

For the year ended 31 December

2016

2017

2018

Sales

£22.7m

£21.2m

£17.9m

EBITDA

£2.1m

£2.2m

£1.0m

 

Lambert recorded order intake of £24.5m in 2018, entering 2019 with a significantly higher order book than the previous year, providing confidence in its expected out-turn for the current financial year.

 

Background to the Acquisition

The Acquisition represents a compelling fit with Mpac's strategic intent of being a market leader in the provision of full-line packaging solutions for the pharmaceutical, healthcare and food and beverage sectors. Lambert typically works upstream in its customers' product and production lifecycle which will enable Mpac to offer a more comprehensive and broader range of automation and packaging solutions to its customers. Mpac will enter the medical and healthcare product assembly and packaging market fulfilling the expected increase in demand for wellness products. Mpac will support Lambert's current strategic plan, exploring the growth opportunities opened by the access to its customer base and global business network.

 

Transaction Highlights

Mpac has acquired the entire issued share capital of Lambert for an initial consideration of £15.0 million, on a cash-free, debt-free basis, to be paid in cash, subject to customary adjustments for working capital. In addition, earn-out consideration will be paid on the basis of a multiple of five times the extent to which the average annual EBITDA of Lambert for the three years ending 31 December 2021 exceeds £2.5 million. The earn-out consideration is capped at a maximum of £2.5 million and will be paid in cash.

It is expected that the Acquisition will be immediately materially earnings enhancing.

It is intended that three of the existing shareholders, including Warren Limbert, Managing Director, will remain with Lambert for at least the next three years. The acquisition of Lambert is expected to deliver sales synergies through cross-selling with the existing Mpac business and access to its global sales and service infrastructure. In addition, cost synergies are expected including through access to Lambert's well-developed supply chain capabilities.

Tony Steels, Chief Executive of Mpac, commented:

"Lambert is a high-quality business with proven performance and long-standing embedded relationships with global blue-chip customers. Clear synergies exist in the market, technologies and supply chain which will provide our customers and potential new customers even greater confidence in the delivery of complete turn-key packaging solutions. Lambert entered 2019 with a significantly higher order book than the previous year and I am excited about the potential of the combined business and the momentum it brings to the fulfilment of our strategic plans.''

 

Trading update

Ahead of the AGM, Mpac Group plc a global leader in 'Make, Pack, Monitor and Service' high speed packaging solutions is pleased to announce the following trading update:

 

Trading performance of the existing business in the current financial year is in line with the Board's and market expectations. Order and quote activity remain strong and the current order book is significantly above the previous year. Additionally, further progress has been made in 2019 to secure the benefits from the delivery of our One Mpac business model and the long-term strategic priorities of, 'Going for Growth', 'Making Service a Business' and delivering improved 'Operational Efficiencies'.

 

 

Tony Steels, Chief Executive, commented:

"I am pleased to report good progress in the trading performance for 2019, of the existing business, supported by growth in order intake and sales over the prior year in both equipment and services backed by a strong orderbook, good levels of quote activity and prospects. The Group has continued the momentum from the second half of 2018 into the start of 2019 and I am confident that we will be able to deliver results for the full year in line with expectation." 

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014

 

 

For further information, please contact:

Mpac Group plc Tel: +44 (0) 2476 421100

Tony Steels, Chief Executive

Will Wilkins, Group Finance Director

 

Panmure Gordon (UK) Limited (Nominated Advisor & Broker) Tel: +44 (0) 20 7886 2500

Dominic Morley

James Stearns

 

Hudson Sandler Tel: +44 (0) 20 7796 4133

Nick Lyon

Nick Moore

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQDBLFXKZFFBBL
Date   Source Headline
26th Apr 20247:35 amRNSSiSTEM pilot battery assembly line
17th Apr 20247:00 amRNSLaunch of ESG Report
9th Apr 20241:12 pmRNSGrant of Options
8th Apr 20242:15 pmRNSNotice of AGM
19th Mar 20247:00 amRNSFull Year Results
21st Feb 20247:00 amRNSEquity Development Investor Presentation
16th Feb 20247:00 amRNSNotice of Results
11th Jan 20247:00 amRNSFull Year Trading Update
4th Dec 202311:51 amRNSDirector/PDMR Shareholding
27th Nov 202311:36 amRNSDirector/PDMR Dealing
18th Oct 20232:42 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSAppointment of Joint Broker
22nd Sep 202311:19 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSHalf Year Results
17th Aug 20237:00 amRNSEquity Development Investor Webinar
11th Jul 20237:00 amRNSTrading Update and Notice of Results
30th May 202310:52 amRNSDirector/PDMR Shareholding
18th May 202311:17 amRNSResult of Annual General Meeting
17th May 20237:00 amRNSAGM Statement
2nd May 20234:37 pmRNSDirector/PDMR Transaction
6th Apr 20235:30 pmRNSAvailability of Annual Report and Notice of AGM
27th Mar 202310:53 amRNSDirector/PDMR Dealing
22nd Mar 20237:01 amRNSCEO succession
22nd Mar 20237:00 amRNSFull Year Results
20th Feb 20237:00 amRNSEquity Development Investor Presentation
17th Feb 20237:00 amRNSNotice of Results
16th Jan 20237:00 amRNSFull Year Trading Update
24th Oct 20222:20 pmRNSDirectorate Appointment
14th Oct 202210:58 amRNSReplacement - PDMR Dealing & Total Voting Rights
12th Oct 20224:59 pmRNSDirector/PDMR Dealing & Total Voting Rights
15th Sep 202212:50 pmRNSMpac signs FREYR framework agreement
13th Sep 20227:00 amRNSEquity Development Investor Presentation
9th Sep 20222:16 pmRNSDirector/PDMR Transaction
8th Sep 20227:00 amRNSHalf Year Result
11th Jul 20227:00 amRNSTrading Update and Notice of Results
24th Jun 20222:54 pmRNSAppointment of new auditor
10th Jun 20224:10 pmRNSGrant of Options
27th May 20222:56 pmRNSDirectors/PDMRs Dealing
25th May 20224:13 pmRNSHolding(s) in Company
19th May 20223:57 pmRNSEBT Subscription & Total Voting Rights
13th May 20224:25 pmRNSDirectors/PDMRs Dealing - Replacement
12th May 20224:46 pmRNSDirectors/PDMRs Dealing
4th May 20224:16 pmRNSResult of AGM
4th May 20227:00 amRNSAGM Statement
17th Mar 20227:00 amRNSFull Year Results
14th Feb 20224:38 pmRNSNotice of Results
12th Jan 20227:00 amRNSFull Year Trading Update
21st Oct 20215:16 pmRNSDirectorate Appointment
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.